Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

01 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/asco-2026--cstone-presents-updated-clinical-data-for-cs2009-pd-1vegfctla-4-trispecific-antibody-reinforcing-triple-target-synergy-and-delivering-strong-proof-of-concept-302786438.html

26 Mar 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-announces-2025-annual-results-accelerated-expansion-of-global-commercial-footprint-and-efficient-advancement-of-innovation-pipeline-2-0--302726269.html

26 Mar 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-updated-clinical-progress-and-key-phase-iii-data-for-cs2009-pd-1vegfctla-4-trispecific-antibody-302726211.html

11 Mar 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-03-11/veristat-expands-regulatory-and-clinical-services-to-chinese-drug-and-device-companies-seeking-effic

23 Feb 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-announces-mhra-approval-in-uk-for-sugemalimab-in-stage-iii-nsclc-302694102.html

15 Feb 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/cstone-announces-fda-clearance-of-ind-application-for-its-novel-trispecific-antibody-cs2009-pd-1vegfctla-4-to-advance-into-phase-ii-clinical-trial-302688307.html
ABOUT THIS PAGE